Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glutamine PET Imaging in LAM

NCT04388371 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04388371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glutamine PET Imaging in LAM
Lead sponsor
Vanderbilt University Medical Center
Phase
Phase 1
Overall status
Completed
Start date
October 18, 2019
Completion date
August 10, 2021
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphangioleiomyomatosis (lam)